Additionally, higher levels of pRKIP were found in the HS group compared to both HR-HS and LC groups, which, in turn, resulted in an overall increase in the RKIP/pRKIP ratio (RpR score) in both at-risk and lung cancer patients (Supporting Figure S1). The gene discussed is PEBP1; the disease is lung carcinoma.